Partager
Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product BLUDIGO™ first indigotindisulfonate sodium, USP, injection drug product approved by FDA.
Partager
Provepharm Life Solutions obtains FDA authorization to produce its active ingredients for the United States Following GMP certification earned in 2019 for its new production unit, Provepharm now has full control over its production chain for Europe and the US.
Partager
Provepharm Inc. authorized by the FDA to distribute SteriMax’s Cefotaxime in the US Temporary Importation of Cefotaxime for Injection to Address Drug Shortage:
Partager
Provepharm Life Solutions raises €120 million New round of funding enables pharma company to make major steps forward in its Horizon 2025 strategy.
Partager
Provepharm Life Solutions acquires Apollo Pharmaceuticals USA to continue growth in the United States Acquisition of high added-value sterile injectable products specialist will enable Provepharm to diversify product portfolio and consolidate position in the US market to prepare for upcoming product launches.
Partager
Provepharm Life Solutions receives €42M New funding will enable pharmaceutical group to accelerate program of international growth through acquisitions.
Partager
Provepharm Life Solutions forms alliance with new strategic partners, ArchiMed and Téthys Invest Partnership reinforces strategy of independent pharmaceutical group Provepharm Life Solutions and constitutes major step forward in its development.
